FDANonrulemakingFDA-2024-D-2033

Who commented on this docket

Expedited Program for Serious Conditions--Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Expedited Program for Serious Conditions--Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 112d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 112d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.